151 related articles for article (PubMed ID: 34302261)
1. Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 2. THR-687.
Vanhove M; Wagner JM; Noppen B; Jonckx B; Vermassen E; Stitt AW
J Pharmacokinet Pharmacodyn; 2021 Dec; 48(6):837-849. PubMed ID: 34302261
[TBL] [Abstract][Full Text] [Related]
2. Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 1. THR-149.
Vanhove M; Noppen B; Wagner JM; Van Bergen T; Barbeaux P; Stitt AW
J Pharmacokinet Pharmacodyn; 2021 Dec; 48(6):825-836. PubMed ID: 34302260
[TBL] [Abstract][Full Text] [Related]
3. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema.
Daull P; Paterson CA; Kuppermann BD; Garrigue JS
J Ocul Pharmacol Ther; 2013 Mar; 29(2):258-69. PubMed ID: 23331052
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of ranibizumab after intravitreal administration in patients with retinal vein occlusion or diabetic macular edema.
Zhang Y; Yao Z; Kaila N; Kuebler P; Visich J; Maia M; Tuomi L; Ehrlich JS; Rubio RG; Campochiaro PA
Ophthalmology; 2014 Nov; 121(11):2237-46. PubMed ID: 25001159
[TBL] [Abstract][Full Text] [Related]
5. A randomized, dose-escalation study of subconjunctival and intravitreal injections of sirolimus in patients with diabetic macular edema.
Dugel PU; Blumenkranz MS; Haller JA; Williams GA; Solley WA; Kleinman DM; Naor J
Ophthalmology; 2012 Jan; 119(1):124-31. PubMed ID: 22115710
[TBL] [Abstract][Full Text] [Related]
6. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
[TBL] [Abstract][Full Text] [Related]
7. Ocular Pharmacokinetics of Therapeutic Antibodies Given by Intravitreal Injection: Estimation of Retinal Permeabilities Using a 3-Compartment Semi-Mechanistic Model.
Hutton-Smith LA; Gaffney EA; Byrne HM; Maini PK; Gadkar K; Mazer NA
Mol Pharm; 2017 Aug; 14(8):2690-2696. PubMed ID: 28631484
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial.
Ahmadieh H; Ramezani A; Shoeibi N; Bijanzadeh B; Tabatabaei A; Azarmina M; Soheilian M; Keshavarzi G; Mohebbi MR
Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):483-9. PubMed ID: 17917738
[TBL] [Abstract][Full Text] [Related]
9. Hypertensive cerebral hemorrhage with undetectable plasma vascular endothelial growth factor levels in a patient receiving intravitreal injection of aflibercept for bilateral diabetic macular edema: a case report.
Yoshimoto M; Takeda N; Yoshimoto T; Matsumoto S
J Med Case Rep; 2021 Jul; 15(1):403. PubMed ID: 34311786
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab versus intravitreal triamcinolone for diabetic macular edema-Systematic review, meta-analysis and meta-regression.
Abdel-Maboud M; Menshawy E; Bahbah EI; Outani O; Menshawy A
PLoS One; 2021; 16(1):e0245010. PubMed ID: 33434220
[TBL] [Abstract][Full Text] [Related]
11. Binding to Ocular Albumin as a Half-Life Extension Principle for Intravitreally Injected Drugs: Evidence from Mechanistic Rat and Rabbit Studies.
Fuchs H; Igney F
J Ocul Pharmacol Ther; 2017 Mar; 33(2):115-122. PubMed ID: 28055308
[TBL] [Abstract][Full Text] [Related]
12. Can Vitreous Reflux Affect The Short-Term Treatment Response After Intravitreal Ranibizumab Injection?
Uyar E; Ulaş F; Alkan Y
Curr Eye Res; 2021 Feb; 46(2):248-254. PubMed ID: 32635750
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA
Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
[TBL] [Abstract][Full Text] [Related]
15. Real-world outcomes following 12 months of intravitreal aflibercept monotherapy in patients with diabetic macular edema in France: results from the APOLLON study.
Korobelnik JF; Daien V; Faure C; Tadayoni R; Giocanti-Auregan A; Dot C; Kodjikian L; Massin P
Graefes Arch Clin Exp Ophthalmol; 2020 Mar; 258(3):521-528. PubMed ID: 31894377
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema.
Synek S; Vojniković B
Coll Antropol; 2010 Apr; 34 Suppl 2():99-103. PubMed ID: 21305729
[TBL] [Abstract][Full Text] [Related]
17. International consortium for innovation and quality: An industry perspective on the nonclinical and early clinical development of intravitreal drugs.
Pruimboom-Brees IM; Gupta S; Chemuturi N; Booler HS; Nimz E; Ferrell Ramos M; Caruso A; Maass KF; Bantseev V; Huang Q; Choules MP; Nussbaum JC; Kanodia J; Thompson C; Durairaj C
Clin Transl Sci; 2023 May; 16(5):723-741. PubMed ID: 36651217
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab with or without triamcinolone acetonide for diabetic macular edema: a meta-analysis of randomized controlled trials.
Liu X; Zhou X; Wang Z; Li T; Jiang B
Chin Med J (Engl); 2014; 127(19):3471-6. PubMed ID: 25269916
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of postvitrectomy intravitreal triamcinolone therapy for diabetic macular edema.
Costa JF; Sousa K; Marques JP; Marques M; Cachulo ML; Silva R; Gomes N; Figueira J
Eur J Ophthalmol; 2016 Aug; 26(5):485-90. PubMed ID: 26951531
[TBL] [Abstract][Full Text] [Related]
20. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
